4//SEC Filing
Brady James Aloysius 4
Accession 0001104659-22-034156
CIK 0001657312other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 6:04 AM ET
Size
5.8 KB
Accession
0001104659-22-034156
Insider Transaction Report
Form 4
Brady James Aloysius
Director
Transactions
- Award
Share Options (Right to Buy)
2022-03-14+288,000→ 288,000 totalExercise: $0.60Exp: 2032-03-13→ Ordinary Shares (288,000 underlying)
Footnotes (2)
- [F1]The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- [F2]The option vests and becomes exercisable as to 25% on August 1, 2022, 25% on November 1, 2022, 25% on February 1, 2023 and 25% on May 1, 2023.
Documents
Issuer
Verona Pharma plc
CIK 0001657312
Entity typeother
Related Parties
1- filerCIK 0001916987
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 6:04 AM ET
- Size
- 5.8 KB